FAP Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of FAP Antibodies for the specific detection and analysis of Fibroblast Activation Protein (FAP). FAP Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fibroblast Activation Protein plays a critical role in the tumor microenvironment, influencing cancer progression and metastasis. FAP is primarily expressed in activated fibroblasts within tumors and is associated with the remodeling of the extracellular matrix, making it a significant target for cancer research and therapeutic interventions. Understanding FAP function is essential for developing strategies to inhibit tumor growth and improve patient outcomes. Researchers worldwide rely on FAP monoclonal antibodies to advance their understanding of tumor biology and metastasis. Current investigations focus on how FAP influences the tumor microenvironment and its potential as a therapeutic target. Ongoing research with FAP monoclonal antibodies continues to reveal new insights about cancer progression mechanisms. Santa Cruz Biotechnology monoclonal antibodies for FAP detection support researchers in their mission to develop more effective cancer treatments and improve patient care.